(NYSE:PFE) shareholders, since the share price is down 43% in the last three years, falling well short of the market return ...

Transcend Capital Advisors LLC reduced its stake in Blackstone Inc. by 4.1%, selling 2,535 shares in Q4. The firm now holds ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd. (BABA), ...

Turnover at catering company was boosted by increased sales and the addition of some new contracts to the business ...

The weight-loss drug market is heating up, with Swiss company Roche making a bold move by acquiring Carmot Therapeutics for up to $3.1 billion in 2023. This investment is aimed at accelerating its ...

These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

PFE offers a 6.73% dividend yield and growth potential, driven by strategic acquisitions, R&D, and discounted valuations.

While smokable product sales are declining slowly, sales of non-smokable products are driving growth for Altria Group. The ...

Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Stock traders ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...